Craig Millian

Amministratore Delegato presso HLS THERAPEUTICS INC.

Patrimonio netto: 73 895 $ in data 31/05/2024

56 anni

Health Technology

Consumer Services

Posizioni attive di Craig Millian

Società	Posizione	Inizio	Fine
HLS THERAPEUTICS INC.	Direttore/Membro del Consiglio	01/05/2023	-
HLS THERAPEUTICS INC.	Amministratore Delegato	01/05/2023	-

Società	Posizione	Inizio	Fine
CORBUS PHARMACEUTICALS HOLDINGS, INC.	Direttore operativo	24/09/2021	14/04/2023
CORBUS PHARMACEUTICALS HOLDINGS, INC.	Corporate Officer/Principal	28/02/2019	24/09/2021
EMD Serono, Inc. EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA.	Corporate Officer/Principal	14/06/2012	01/12/2018
VERTEX PHARMACEUTICALS INCORPORATED	Corporate Officer/Principal	-	-

University of Pennsylvania	Undergraduate Degree
New York University	Masters Business Admin

Distribuzione geografica

Stati Uniti	6
Canada	2

Posizioni

Corporate Officer/Principal	3
Undergraduate Degree	1
Masters Business Admin	1

Settori

Health Technology	5
Consumer Services	3

Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Società quotate in Borsa	3
CORBUS PHARMACEUTICALS HOLDINGS, INC.	Health Technology
VERTEX PHARMACEUTICALS INCORPORATED	Health Technology
HLS THERAPEUTICS INC.	Health Technology

Aziende private	1
EMD Serono, Inc. EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA.	Health Technology